Product
Peg-IFNα-2b
2 clinical trials
1 indication
Indication
Chronic Hepatitis BClinical trial
The Safety and Efficacy of PD-1 Antibody Combined With Pegylated Interferon-α Therapy to Promote the Clinical Cure in Nucleoside (Acid) Analogues-suppressed Chronic Hepatitis B Patients: A Protocol for the Prospective Pilot StudyStatus: Recruiting, Estimated PCD: 2025-10-30
Clinical trial
The Safety and Efficacy of Sequential Combination Therapy With PD-1 Antibody and Pegylated Interferon-α in NA-supressed Chronic Hepatitis B PatientsStatus: Recruiting, Estimated PCD: 2025-12-15